SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
New Technologies Offer More Accurate Means Of Diagnosis And Monitoring Cancer
April 21, 2008
 · 
1 min read
Lone Star Bio
Treatment Bias Can Skew Results of Observational Studies, University of Texas M. D. Anderson Cancer Center
April 21, 2008
 · 
1 min read
Drug Development
New Type Of Drug Shrinks Primary Breast Cancer Tumors Significantly In Just 6 Weeks, Baylor College of Medicine Study Shows
April 17, 2008
 · 
1 min read
Lone Star Bio
Saliva Can Help Diagnose Heart Attack, University of Texas Study Shows
April 17, 2008
 · 
1 min read
Lone Star Bio
Mouth Swab May One Day Diagnose Lung Cancer, M. D. Anderson Cancer Center Study
April 17, 2008
 · 
1 min read
Lone Star Bio
High Doses of Vitamin E Lengthen Lives of Alzheimer’s Patients, Baylor College of Medicine Study
April 16, 2008
 · 
1 min read
Lone Star Bio
Mouth Test Could Predict Lung Cancer, University of Texas M. D. Anderson Cancer Center Study Finds
April 14, 2008
 · 
1 min read
Lone Star Bio
Salt-tolerant Gene Found In Simple Plant Nothing To Sneeze At, Texas A&M University Study
April 8, 2008
 · 
1 min read
Lone Star Bio
Drug Trials Suffer From Little Diversity
April 3, 2008
 · 
1 min read
Lone Star Bio
Gene Mutations Tied To Immune Comeback During Therapy For HIV-1, University of Texas Health Science Center
April 2, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
November 21, 2025
 · 
1 min read
Press Releases
CrossBridge Bio Awarded $15 Million CPRIT Grant to Advance CBB-120, Its Lead Dual-Payload ADC Targeting TROP-2, Into the Clinic
November 21, 2025
 · 
2 min read
Press Releases
Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus® Brain-Computer Interface
November 21, 2025
 · 
4 min read
Press Releases
Tekton Research Adds Two New Sites to Expand Neuroscience and General Medicine Capabilities in Key U.S. Markets
November 21, 2025
 · 
3 min read
Press Releases
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
November 21, 2025
 · 
5 min read
Press Releases
Former US Congressman Dr. Brad Wenstrup Joins Maxwell Board
November 20, 2025
 · 
3 min read
Press Releases
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2025
 · 
6 min read
Press Releases
Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
November 20, 2025
 · 
4 min read
Press Releases
Cellipont Bioservices and Ronawk Partner to Advance Scalable Expansion of High-Quality Mesenchymal Stem Cells and Biologics
November 20, 2025
 · 
3 min read
Press Releases
EMILY SEDGWICK, M.D., NAMED CHIEF MEDICAL OFFICER OF SOLIS MAMMOGRAPHY
November 20, 2025
 · 
3 min read
Load More